Interleukin 29: Difference between revisions
Jump to navigation
Jump to search
m Bot: HTTP→HTTPS |
imported>JCW-CleanerBot m →Further reading: clean up, replaced: Acta Crystallographica. Section F, Structural Biology and Crystallization Communications → Acta Crystallographica Section F |
||
| Line 15: | Line 15: | ||
* {{cite journal | vauthors = Uzé G, Monneron D | title = IL-28 and IL-29: newcomers to the interferon family | journal = Biochimie | volume = 89 | issue = 6-7 | pages = 729–34 | year = 2007 | pmid = 17367910 | doi = 10.1016/j.biochi.2007.01.008 }} | * {{cite journal | vauthors = Uzé G, Monneron D | title = IL-28 and IL-29: newcomers to the interferon family | journal = Biochimie | volume = 89 | issue = 6-7 | pages = 729–34 | year = 2007 | pmid = 17367910 | doi = 10.1016/j.biochi.2007.01.008 }} | ||
* {{cite journal | vauthors = Hou W, Wang X, Ye L, Zhou L, Yang ZQ, Riedel E, Ho WZ | title = Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages | journal = Journal of Virology | volume = 83 | issue = 8 | pages = 3834–42 | date = April 2009 | pmid = 19193806 | pmc = 2663280 | doi = 10.1128/JVI.01773-08 }} | * {{cite journal | vauthors = Hou W, Wang X, Ye L, Zhou L, Yang ZQ, Riedel E, Ho WZ | title = Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages | journal = Journal of Virology | volume = 83 | issue = 8 | pages = 3834–42 | date = April 2009 | pmid = 19193806 | pmc = 2663280 | doi = 10.1128/JVI.01773-08 }} | ||
* {{cite journal | vauthors = Magracheva E, Pletnev S, Kotenko S, Li W, Wlodawer A, Zdanov A | title = Purification, crystallization and preliminary crystallographic studies of the complex of interferon-lambda1 with its receptor | journal = Acta Crystallographica | * {{cite journal | vauthors = Magracheva E, Pletnev S, Kotenko S, Li W, Wlodawer A, Zdanov A | title = Purification, crystallization and preliminary crystallographic studies of the complex of interferon-lambda1 with its receptor | journal = Acta Crystallographica Section F | volume = 66 | issue = Pt 1 | pages = 61–3 | date = January 2010 | pmid = 20057073 | pmc = 2805539 | doi = 10.1107/S1744309109048817 }} | ||
* {{cite journal | vauthors = Stoltz M, Klingström J | title = Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection | journal = Journal of Virology | volume = 84 | issue = 18 | pages = 9140–8 | date = September 2010 | pmid = 20592090 | pmc = 2937636 | doi = 10.1128/JVI.00717-10 }} | * {{cite journal | vauthors = Stoltz M, Klingström J | title = Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection | journal = Journal of Virology | volume = 84 | issue = 18 | pages = 9140–8 | date = September 2010 | pmid = 20592090 | pmc = 2937636 | doi = 10.1128/JVI.00717-10 }} | ||
* {{cite journal | vauthors = Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diebold J, Diepolder H, Adler B, Auernhammer CJ, Göke B, Dambacher J | title = IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression | journal = American Journal of Physiology. Gastrointestinal and Liver Physiology | volume = 289 | issue = 5 | pages = G960-8 | date = November 2005 | pmid = 16051921 | doi = 10.1152/ajpgi.00126.2005 }} | * {{cite journal | vauthors = Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diebold J, Diepolder H, Adler B, Auernhammer CJ, Göke B, Dambacher J | title = IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression | journal = American Journal of Physiology. Gastrointestinal and Liver Physiology | volume = 289 | issue = 5 | pages = G960-8 | date = November 2005 | pmid = 16051921 | doi = 10.1152/ajpgi.00126.2005 }} | ||
| Line 34: | Line 34: | ||
{{Interleukins}} | {{Interleukins}} | ||
{{Interleukin receptor modulators}} | {{Interleukin receptor modulators}} | ||
[[Category:Interleukins]] | |||
{{immunology-stub}} | {{immunology-stub}} | ||
Latest revision as of 14:23, 10 October 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
Interleukin-29 (IL-29) is a protein that in humans is encoded by the IL29 gene that resides on chromosome 19.[1][2]
IL-29 is a member of the helical cytokine family and is a type III interferon.[3] It is also known as IFNλ1 and is highly similar in amino acid sequence to the IL-28, the other type III interferon. IL-29 plays an important role in host defenses against microbes and its gene is highly upregulated in cells infected with viruses. IL29 is not present in the mouse genome.
References
- ↑ "Entrez Gene: interleukin 29 (interferon".
- ↑ Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM (January 2003). "IL-28, IL-29 and their class II cytokine receptor IL-28R". Nature Immunology. 4 (1): 63–8. doi:10.1038/ni873. PMID 12469119.
- ↑ Vilcek J (January 2003). "Novel interferons". Nature Immunology. 4 (1): 8–9. doi:10.1038/ni0103-8. PMID 12496969.
Further reading
- Pagliaccetti NE, Eduardo R, Kleinstein SH, Mu XJ, Bandi P, Robek MD (October 2008). "Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication". The Journal of Biological Chemistry. 283 (44): 30079–89. doi:10.1074/jbc.M804296200. PMC 2662072. PMID 18757365.
- Li MC, Wang HY, Wang HY, Li T, He SH (April 2006). "Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells". Acta Pharmacologica Sinica. 27 (4): 453–9. doi:10.1111/j.1745-7254.2006.00292.x. PMID 16539846.
- Megjugorac NJ, Gallagher GE, Gallagher G (December 2009). "Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29)". Journal of Leukocyte Biology. 86 (6): 1359–63. doi:10.1189/jlb.0509347. PMID 19759281.
- Uzé G, Monneron D (2007). "IL-28 and IL-29: newcomers to the interferon family". Biochimie. 89 (6–7): 729–34. doi:10.1016/j.biochi.2007.01.008. PMID 17367910.
- Hou W, Wang X, Ye L, Zhou L, Yang ZQ, Riedel E, Ho WZ (April 2009). "Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages". Journal of Virology. 83 (8): 3834–42. doi:10.1128/JVI.01773-08. PMC 2663280. PMID 19193806.
- Magracheva E, Pletnev S, Kotenko S, Li W, Wlodawer A, Zdanov A (January 2010). "Purification, crystallization and preliminary crystallographic studies of the complex of interferon-lambda1 with its receptor". Acta Crystallographica Section F. 66 (Pt 1): 61–3. doi:10.1107/S1744309109048817. PMC 2805539. PMID 20057073.
- Stoltz M, Klingström J (September 2010). "Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection". Journal of Virology. 84 (18): 9140–8. doi:10.1128/JVI.00717-10. PMC 2937636. PMID 20592090.
- Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diebold J, Diepolder H, Adler B, Auernhammer CJ, Göke B, Dambacher J (November 2005). "IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression". American Journal of Physiology. Gastrointestinal and Liver Physiology. 289 (5): G960–8. doi:10.1152/ajpgi.00126.2005. PMID 16051921.
- Pekarek V, Srinivas S, Eskdale J, Gallagher G (March 2007). "Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner". Genes and Immunity. 8 (2): 177–80. doi:10.1038/sj.gene.6364372. PMID 17252004.
- Li M, Liu X, Zhou Y, Su SB (July 2009). "Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses". Journal of Leukocyte Biology. 86 (1): 23–32. doi:10.1189/jlb.1208761. PMID 19304895.
- Jordan WJ, Eskdale J, Boniotto M, Rodia M, Kellner D, Gallagher G (January 2007). "Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29)". Genes and Immunity. 8 (1): 13–20. doi:10.1038/sj.gene.6364348. PMID 17082759.
- Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ (February 2009). "Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection". Journal of Immunology. 182 (3): 1296–304. doi:10.4049/jimmunol.182.3.1296. PMID 19155475.
- Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, Tian B, Reuhl K, Dickensheets H, Sheikh F, Donnelly RP, Raveche E, Kotenko SV (April 2006). "Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma". Cancer Research. 66 (8): 4468–77. doi:10.1158/0008-5472.CAN-05-3653. PMID 16618774.
- Osterlund P, Veckman V, Sirén J, Klucher KM, Hiscott J, Matikainen S, Julkunen I (August 2005). "Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells". Journal of Virology. 79 (15): 9608–17. doi:10.1128/JVI.79.15.9608-9617.2005. PMC 1181545. PMID 16014923.
- Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, Donnelly RP, Gamero AM (July 2008). "IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity". Cancer Biology & Therapy. 7 (7): 1109–15. doi:10.4161/cbt.7.7.6192. PMC 2435218. PMID 18698163.
- Mennechet FJ, Uzé G (June 2006). "Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells". Blood. 107 (11): 4417–23. doi:10.1182/blood-2005-10-4129. PMID 16478884.
- Wolk K, Witte K, Witte E, Proesch S, Schulze-Tanzil G, Nasilowska K, Thilo J, Asadullah K, Sterry W, Volk HD, Sabat R (May 2008). "Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes". Journal of Leukocyte Biology. 83 (5): 1181–93. doi:10.1189/jlb.0807525. PMID 18281438.
- Novak AJ, Grote DM, Ziesmer SC, Rajkumar V, Doyle SE, Ansell SM (December 2008). "A role for IFN-lambda1 in multiple myeloma B cell growth". Leukemia. 22 (12): 2240–6. doi:10.1038/leu.2008.263. PMC 2771776. PMID 18830264.
- Witte K, Gruetz G, Volk HD, Looman AC, Asadullah K, Sterry W, Sabat R, Wolk K (December 2009). "Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines". Genes and Immunity. 10 (8): 702–14. doi:10.1038/gene.2009.72. PMID 19798076.
- Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour JF, Furrer H, Günthard HF, Heim M, Hirschel B, Malinverni R, Moradpour D, Müllhaupt B, Witteck A, Beckmann JS, Berg T, Bergmann S, Negro F, Telenti A, Bochud PY (April 2010). "Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study". Gastroenterology. 138 (4): 1338–45, 1345.e1–7. doi:10.1053/j.gastro.2009.12.056. PMID 20060832.
 | This immunology article is a stub. You can help Wikipedia by expanding it. |